Daratumumab plus Bortezomib/Lenalidomide/ Dexamethasone in Patients With Transplant-ineligible or Transplant-deferred Newly Diagnosed Multiple Myeloma: Results of the Phase 3 CEPHEUS Study

被引:0
作者
Usmani, Saad Z. [1 ]
Facon, Thierry [2 ]
Hungria, Vania [3 ]
Bahlis, Nizar J. [4 ]
Venner, Christopher P. [5 ,6 ]
Braunstein, Marc [7 ]
Pour, Ludek [8 ]
Marti, Josep [9 ]
Basu, Supratik [10 ,11 ]
Cohen, Yael C. [12 ]
Matsumoto, Morio [13 ]
Suzuki, Kenshi [14 ]
Hulin, Cyrille [15 ]
Grosicki, Sebastian [16 ]
Legiec, Wojciech [17 ]
Beksac, Meral [18 ]
Maiolino, Angelo [19 ]
Liu, Weiping [20 ]
Wang, Jianping [21 ]
Krevvata, Maria [21 ]
Lopez-Masi, Lorena [22 ]
Carey, Jodi [21 ]
Rowe, Melissa [23 ]
Carson, Robin [21 ]
Zweegman, Sonja [24 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Univ Lille, CHU Lille, Serv Malad Sang, Lille, France
[3] Clin Med Sao Germano, Sao Paulo, Brazil
[4] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada
[5] Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada
[6] Univ British Columbia, BC Canc Vancouver Ctr, Vancouver, BC, Canada
[7] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA
[8] Univ Hosp Brno, Brno, Czech Republic
[9] Hosp Univ Mutua Terrassa, Terrassa, Spain
[10] Royal Wolverhampton NHS Trust, Wolverhampton, England
[11] Univ Wolverhampton, CRN West Midlands, NIHR, Wolverhampton, England
[12] Tel Aviv Univ, Fac Med & Hlth Sci, Tel Aviv Sourasky Ichilov Med Ctr, Tel Aviv, Israel
[13] Natl Hosp Org, Dept Hematol, Shibukawa Med Ctr, Gunma, Japan
[14] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan
[15] Univ Hosp, Dept Hematol, Hop Haut Leveque, Pessac, France
[16] Med Univ Silesian, Sch Publ Hlth, Dept Hematol & Canc Prevent, Katowice, Poland
[17] St John Dukla Oncol Ctr Lublin Land, Dept Hematol & Bone Marrow Transplantat, Lublin, Poland
[18] Istinye Univ, Ankara Liv Hosp, Ankara, Turkiye
[19] Inst Amer Ensino Pesquisa & Inovacao, Rio De Janeiro, Brazil
[20] Janssen Res & Dev, Shanghai, Peoples R China
[21] Janssen Res & Dev LLC, Spring House, PA USA
[22] Janssen Res & Dev LLC, Raritan, NJ USA
[23] Janssen Res & Dev LLC, High Wycombe, Bucks, England
[24] Vrije Univ Amsterdam, Dept Hematol, Canc Ctr Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OA-63
引用
收藏
页码:S288 / S289
页数:2
相关论文
共 50 条
[21]   Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Maia Study [J].
Kumar, Shaji K. ;
Moreau, Philippe ;
Bahlis, Nizar Jacques ;
Facon, Thierry ;
Plesner, Torben ;
Orlowski, Robert Z. ;
Basu, Supratik ;
Nahi, Hareth ;
Hulin, Cyrille ;
Quach, Hang ;
Goldschmidt, Hartmut ;
O'Dwyer, Michael ;
Perrot, Aurore ;
Venner, Christopher P. ;
Weisel, Katja ;
Raje, Noopur ;
Tiab, Mourad ;
Macro, Margaret ;
Frenzel, Laurent ;
Leleu, Xavier ;
Pei, Huiling ;
Krevvata, Maria ;
Carson, Robin ;
Borgsten, Fredrik ;
Usmani, Saad .
BLOOD, 2022, 140 :10150-10153
[22]   Isatuximab, Plus Bortezomib, Lenalidomide, and Dexamethasone (VRd) for Newly Diagnosed Multiple Myeloma (NDMM) Transplant-ineligible Patients: Frailty Subgroup Analysis of IMROZ [J].
Manier, Salomon ;
Dimopoulos, Meletios-Athanasios ;
Leleu, Xavier ;
Moreau, Philippe ;
Cavo, Michele ;
Goldschmidt, Hartmut ;
Orlowski, Robert Z. ;
Tron, Muriel ;
Tekle, Christina ;
Bregeault, Marie-France ;
Shafer, Andrea ;
Beksac, Meral ;
Facon, Thierry .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S290-S291
[23]   Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma [J].
Benboubker, Lotfi ;
Dimopoulos, Meletios A. ;
Dispenzieri, Angela ;
Catalano, John ;
Belch, Andrew R. ;
Cavo, Michele ;
Pinto, Antonello ;
Weisel, Katja ;
Ludwig, Heinz ;
Bahlis, Nizar ;
Banos, Anne ;
Tiab, Mourad ;
Delforge, Michel ;
Cavenagh, Jamie ;
Geraldes, Catarina ;
Lee, Je-Jung ;
Chen, Christine ;
Oriol, Albert ;
de la Rubia, Javier ;
Qiu, Lugui ;
White, Darrell J. ;
Binder, Daniel ;
Anderson, Kenneth ;
Fermand, Jean-Paul ;
Moreau, Philippe ;
Attal, Michel ;
Knight, Robert ;
Chen, Guang ;
Van Oostendorp, Jason ;
Jacques, Christian ;
Ervin-Haynes, Annette ;
Avet-Loiseau, Herve ;
Hulin, Cyrille ;
Facon, Thierry .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (10) :906-917
[24]   Phase 3 MAIA Study: Overall Survival (OS) Results with Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (TIE-NDMM) [J].
Orlowski, Robert ;
Facon, Thierry ;
Kumar, Shaji ;
Plesner, Torben ;
Moreau, Philippe ;
Bahlis, Nizar ;
Basu, Supratik ;
Nahi, Hareth ;
Hulin, Cyrille ;
Quach, Hang ;
Goldschmidt, Hartmut ;
O'Dwyer, Michael ;
Perrot, Aurore ;
Venner, Christopher ;
Weisel, Katja ;
Mace, Joseph ;
Raje, Noopur ;
Tiab, Mourad ;
Macro, Margaret ;
Frenzel, Laurent ;
Leleu, Xavier ;
Ahmadi, Tahamtan ;
Wang, Jianping ;
Van Rampelbergh, Rian ;
Uhlar, Clarissa ;
Tromp, Brenda ;
Delioukina, Maria ;
Vermeulen, Jessica ;
Usmani, Saad .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 :S424-S425
[25]   Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN [J].
Ajay K. Nooka ;
Jonathan L. Kaufman ;
Cesar Rodriguez ;
Andrzej Jakubowiak ;
Yvonne Efebera ;
Brandi Reeves ;
Tanya Wildes ;
Sarah A. Holstein ;
Larry D. Anderson ;
Ashraf Badros ;
Leyla Shune ;
Ajai Chari ;
Huiling Pei ;
Annelore Cortoos ;
Sharmila Patel ;
J. Blake Bartlett ;
Jessica Vermeulen ;
Thomas S. Lin ;
Paul G. Richardson ;
Peter Voorhees .
Blood Cancer Journal, 12
[26]   Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN [J].
Nooka, Ajay K. ;
Kaufman, Jonathan L. ;
Rodriguez, Cesar ;
Jakubowiak, Andrzej ;
Efebera, Yvonne ;
Reeves, Brandi ;
Wildes, Tanya ;
Holstein, Sarah A. ;
Anderson, Larry D., Jr. ;
Badros, Ashraf ;
Shune, Leyla ;
Chari, Ajai ;
Pei, Huiling ;
Cortoos, Annelore ;
Patel, Sharmila ;
Bartlett, J. Blake ;
Vermeulen, Jessica ;
Lin, Thomas S. ;
Richardson, Paul G. ;
Voorhees, Peter .
BLOOD CANCER JOURNAL, 2022, 12 (04)
[27]   Overall survival and progression-free survival by treatment duration with Daratumumab plus Lenalidomide/Dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: phase 3 MAIA study [J].
Moreau, Philippe ;
Facon, Thierry ;
Kumar, Shaji ;
Plesner, Torben ;
Orlowski, Robert Z. ;
Bahlis, Nizar ;
Basu, Supratik ;
Nahi, Hareth ;
Hulin, Cyrille ;
Quach, Hang ;
Goldschmidt, Hartmut ;
O'Dwyer, Michael ;
Perrot, Aurore ;
Venner, Christopher ;
Weisel, Katja ;
Mace, Joseph R. ;
Raje, Noopur ;
Tiab, Mourad ;
Macro, Margaret ;
Frenzel, Laurent ;
Leleu, Xavier ;
Pei, Huiling ;
Tromp, Brenda ;
Delioukina, Maria ;
Usmani, Saad Z. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 :S1-S1
[28]   Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial [J].
Leleu, Xavier ;
Hulin, Cyrille ;
Lambert, Jerome ;
Bobin, Arthur ;
Perrot, Aurore ;
Karlin, Lionel ;
Roussel, Murielle ;
Montes, Lydia ;
Cherel, Brieuc ;
Chalopin, Thomas ;
Slama, Borhane ;
Chretien, Marie-Lorraine ;
Laribi, Kamel ;
Dingremont, Claire ;
Roul, Christophe ;
Mariette, Clara ;
Rigaudeau, Sophie ;
Calmettes, Claire ;
Dib, Mamoun ;
Tiab, Mourad ;
Vincent, Laure ;
Delaunay, Jacques ;
Santagostino, Alberto ;
Macro, Margaret ;
Bourgeois, Emmanuelle ;
Orsini-Piocelle, Frederique ;
Gay, Julie ;
Bareau, Benoit ;
Bigot, Noemie ;
Vergez, Francois ;
Lebreton, Pierre ;
Tabrizi, Reza ;
Waultier-Rascalou, Agathe ;
Frenzel, Laurent ;
Le Calloch, Ronan ;
Chalayer, Emilie ;
Braun, Thorsten ;
Lachenal, Florence ;
Corm, Selim ;
Kennel, Celine ;
Belkhir, Rakiba ;
Blade, Jean-Sebastien ;
Joly, Bertrand ;
Richez-Olivier, Valentine ;
Gardeney, Helene ;
Demarquette, Helene ;
Robu-Cretu, Daniela ;
Garderet, Laurent ;
Newinger-Porte, Muriel ;
Kasmi, Amine .
NATURE MEDICINE, 2024, 30 (08) :2235-2241
[29]   Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: part 1 results of a phase I/II study [J].
Terpos, Evangelos ;
Gavriatopoulou, Maria ;
Ntanasis-Stathopoulos, Ioannis ;
Malandrakis, Panagiotis ;
Fotiou, Despina ;
Migkou, Magdalini ;
Theodorakakou, Foteini ;
Spiliopoulou, Vasiliki ;
Kostopoulos, Ioannis V. ;
Syrigou, Rodanthi-Eleni ;
Eleutherakis-Papaiakovou, Evangelos ;
Gkolfinopoulos, Stavros ;
Tsitsilonis, Ourania E. ;
Kastritis, Efstathios ;
Dimopoulos, Meletios A. .
HAEMATOLOGICA, 2024, 109 (08) :2594-2605
[30]   Cost-effectiveness of lenalidomide plus dexamethasone vs bortezomib plus melphalan and prednisone in transplant-ineligible US patients with newly-diagnosed multiple myeloma [J].
Usmani, S. Z. ;
Cavenagh, J. D. ;
Belch, A. R. ;
Hulin, C. ;
Basu, S. ;
White, D. ;
Nooka, A. ;
Ervin-Haynes, A. ;
Yiu, W. ;
Nagarwala, Y. ;
Berger, A. ;
Pelligra, C. G. ;
Guo, S. ;
Binder, G. ;
Gibson, C. J. ;
Facon, T. .
JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (03) :243-258